JP2015221806A5 - - Google Patents

Download PDF

Info

Publication number
JP2015221806A5
JP2015221806A5 JP2015133015A JP2015133015A JP2015221806A5 JP 2015221806 A5 JP2015221806 A5 JP 2015221806A5 JP 2015133015 A JP2015133015 A JP 2015133015A JP 2015133015 A JP2015133015 A JP 2015133015A JP 2015221806 A5 JP2015221806 A5 JP 2015221806A5
Authority
JP
Japan
Prior art keywords
acid
dosage form
oral dosage
pharmaceutically acceptable
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015133015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015221806A (ja
JP6258264B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015221806A publication Critical patent/JP2015221806A/ja
Publication of JP2015221806A5 publication Critical patent/JP2015221806A5/ja
Application granted granted Critical
Publication of JP6258264B2 publication Critical patent/JP6258264B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015133015A 2006-08-08 2015-07-01 ヒトの血小板レベルを増加させるための組成物および方法 Active JP6258264B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83633406P 2006-08-08 2006-08-08
US60/836,334 2006-08-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012239767A Division JP2013047257A (ja) 2006-08-08 2012-10-31 ヒトの血小板レベルを増加させるための組成物および方法

Publications (3)

Publication Number Publication Date
JP2015221806A JP2015221806A (ja) 2015-12-10
JP2015221806A5 true JP2015221806A5 (enExample) 2016-06-30
JP6258264B2 JP6258264B2 (ja) 2018-01-10

Family

ID=39082656

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009523867A Pending JP2010500361A (ja) 2006-08-08 2007-08-08 ヒトの血小板レベルを増加させるための組成物および方法
JP2012239767A Withdrawn JP2013047257A (ja) 2006-08-08 2012-10-31 ヒトの血小板レベルを増加させるための組成物および方法
JP2015133015A Active JP6258264B2 (ja) 2006-08-08 2015-07-01 ヒトの血小板レベルを増加させるための組成物および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2009523867A Pending JP2010500361A (ja) 2006-08-08 2007-08-08 ヒトの血小板レベルを増加させるための組成物および方法
JP2012239767A Withdrawn JP2013047257A (ja) 2006-08-08 2012-10-31 ヒトの血小板レベルを増加させるための組成物および方法

Country Status (8)

Country Link
US (2) US20080039475A1 (enExample)
EP (2) EP2452674B1 (enExample)
JP (3) JP2010500361A (enExample)
AU (2) AU2007284644B2 (enExample)
CA (1) CA2660283C (enExample)
ES (2) ES2470333T3 (enExample)
IL (4) IL196897A (enExample)
WO (1) WO2008021283A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4120586B2 (ja) * 2002-01-18 2008-07-16 アステラス製薬株式会社 ２−アシルアミノチアゾール誘導体又はその塩
JP2013501811A (ja) * 2009-08-14 2013-01-17 エーザイ インコーポレーテッド 血小板産生を刺激するためのｅ５５０１の使用
CN112022825B (zh) * 2020-08-24 2024-03-22 瑞阳制药股份有限公司 马来酸阿伐曲泊帕片剂及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
US5256675A (en) * 1989-08-07 1993-10-26 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
GB9126677D0 (en) * 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
DE59401177D1 (de) * 1993-04-08 1997-01-16 Abb Management Ag Misch- und Flammenstabilisierungseinrichtung in einer Brennkammer mit Vormischverbrennung
EP0768311B1 (en) * 1995-03-09 2003-08-06 Kyowa Hakko Kogyo Co., Ltd. Pyrrolocarbazole derivatives
US5750540A (en) * 1995-04-28 1998-05-12 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
US6083913A (en) * 1995-06-07 2000-07-04 Glaxo Wellcome Inc. Peptides and compounds that bind to a thrombopoietin receptor
US5963666A (en) * 1995-08-18 1999-10-05 International Business Machines Corporation Confusion matrix mediated word prediction
US6040335A (en) * 1995-10-17 2000-03-21 Suntory Limited Therapeutics for thrombocytopenia
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6187797B1 (en) * 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
JP2002526482A (ja) * 1998-09-18 2002-08-20 バーテックス ファーマシューティカルズ インコーポレイテッド ｐ３８のインヒビター
JP2002529502A (ja) * 1998-11-17 2002-09-10 スミスクライン・ビーチャム・コーポレイション 血小板減少症の治療法
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
JPWO2002062775A1 (ja) * 2001-02-02 2004-06-10 山之内製薬株式会社 ２−アシルアミノチアゾール誘導体又はその塩
US7199124B2 (en) * 2001-02-02 2007-04-03 Takeda Pharmaceutical Company Limited JNK inhibitor
JP4120586B2 (ja) * 2002-01-18 2008-07-16 アステラス製薬株式会社 ２−アシルアミノチアゾール誘導体又はその塩
AU2003243921B2 (en) * 2002-06-27 2009-05-07 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
WO2004029049A1 (ja) 2002-09-30 2004-04-08 Yamanouchi Pharmaceutical Co., Ltd. 2-アシルアミノチアゾール誘導体の新規な塩
CA2523125A1 (en) * 2003-03-25 2004-10-14 Vertex Pharmaceuticals Incorporated Thiazoles useful as inhibitors of protein kinases
MXPA06000441A (es) * 2003-07-17 2006-04-05 Astellas Pharma Inc Derivado de 2-acilaminotiazole o sal del mismo.
KR100776961B1 (ko) * 2003-08-12 2007-11-28 시오노기세이야쿠가부시키가이샤 트롬보포이에틴 수용체 아고니스트 작용을 가지는 화합물
WO2007054783A2 (en) * 2005-11-08 2007-05-18 Astellas Pharma Inc. Compositions and methods for treating thrombocytopenia

Similar Documents

Publication Publication Date Title
JP2017528503A5 (enExample)
JP2012193216A5 (enExample)
JP2016534063A5 (enExample)
JP2018534348A5 (enExample)
JP2017537126A5 (enExample)
JP2012255026A5 (enExample)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
JP2018524298A5 (enExample)
JP2019516684A5 (enExample)
JP2015155440A5 (enExample)
ME02150B (me) Derivati piperidinona kao inhibitori mdm2 za lečenje kancera
JP2013544850A5 (enExample)
JP2015187156A5 (enExample)
JP2015524472A5 (enExample)
JP2008533007A5 (enExample)
JP2012513416A5 (enExample)
JP2014500861A5 (enExample)
RU2006140964A (ru) Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин
JP2018531273A5 (enExample)
MX2021015827A (es) Antagonista de neurokinin -1.
JP2016507500A5 (enExample)
JP2016512818A5 (enExample)
JP2015221806A5 (enExample)
JP2012510985A5 (enExample)
JP2016532632A5 (enExample)